Long-term (104-Week) Efficacy and Safety Profile of Apremilast, an Oral Phosphodiesterase 4 Inhibitor, in Patients with Psoriatic Arthritis: Results from a Phase III, Randomized, Controlled Trial and Open-Label Extension (PALACE 1)

Gómez-Reino Carnota, Juan Jesús

Statistics

Statistics

View Usage Statistics

Identifiers

Identifiers

URI: http://hdl.handle.net/20.500.11940/3490

ISSN: 0315-162X

Full record

Services

Services

RIS

Mendeley

Linksolver

Date issued

2015

Journal title

JOURNAL OF RHEUMATOLOGY

Type of content

Publicación de congreso